XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2016   10,793,946    
Beginning balance at Dec. 31, 2016 $ 172,521 $ 60,831 $ 111,693 $ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 14,502   14,502  
Net unrealized gain on securities available for sale, net of tax 110     110
Net unrealized gain on cash flow hedging derivative instruments, net of tax (128)     (128)
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (11)     (11)
Comprehensive income 14,473   14,502 (29)
Cash dividends declared (7,682)   (7,682)  
Equity compensation expense 247 $ 247    
Payment to repurchase of common stock (in shares)   (5,560)    
Payment to repurchase common stock $ (153)   (153)  
Issuance of restricted stock (in shares) 0 18,850    
Proceeds from sale of common stock (in shares)   17,488    
Proceeds from sale of common stock $ 476 $ 476    
Ending balance (in shares) at Sep. 30, 2017 10,824,724 10,824,724    
Ending balance at Sep. 30, 2017 $ 179,882 $ 61,554 118,360 (32)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 4,982      
Net unrealized gain on securities available for sale, net of tax (240)      
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax $ (3)      
Ending balance (in shares) at Sep. 30, 2017 10,824,724 10,824,724    
Ending balance at Sep. 30, 2017 $ 179,882 $ 61,554 118,360 (32)
Beginning balance (in shares) at Dec. 31, 2017 10,829,918 10,829,918    
Beginning balance at Dec. 31, 2017 $ 181,321 $ 61,855 121,144 (1,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 17,173   17,173  
Net unrealized gain on securities available for sale, net of tax (6,232)     (6,232)
Net unrealized gain on cash flow hedging derivative instruments, net of tax 738     738
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (20)     (20)
Comprehensive income 11,659   17,173 (5,514)
Cash dividends declared (8,902)   (8,902)  
Equity compensation expense 285 $ 285    
Payment to repurchase of common stock (in shares)   (5,725)    
Payment to repurchase common stock $ (168)   (168)  
Issuance of restricted stock (in shares) 0 16,795    
Proceeds from sale of common stock (in shares)   16,128    
Proceeds from sale of common stock $ 466 $ 466    
Ending balance (in shares) at Sep. 30, 2018 10,857,116 10,857,116    
Ending balance at Sep. 30, 2018 $ 184,661 $ 62,606 129,247 (7,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,933      
Net unrealized gain on securities available for sale, net of tax (1,888)      
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax $ (5)      
Ending balance (in shares) at Sep. 30, 2018 10,857,116 10,857,116    
Ending balance at Sep. 30, 2018 $ 184,661 $ 62,606 $ 129,247 $ (7,192)